乐天堂fun88

Mesenchymal Stem Cells (MSCs)

Mesenchymal Stem Cells (MSCs)

Mesenchymal stem cells (MSCs) are important members of the stem cell family, originating from the mesoderm in early development. They are pluripotent stem cells, attracting attention due to their self-replication, self-renewal, multi-lineage differentiation potential, hematopoietic support, and ability to promote stem cell engraftment. Furthermore, MSCs exhibit low immunogenicity and unique immunomodulatory effects, enabling them to evade immune recognition, suppress immune responses, and possess homing and damage chemotaxis. Shenzhen Cell Valley can provide high-purity, high-vitality MSCs for basic and clinical research.
Description

Overview

Mesenchymal stem cells (MSCs  ) are important members of the stem cell family, originating from the mesoderm in early development. They are pluripotent stem cells, attracting attention due to their self-replication, self-renewal, multi-lineage differentiation potential, hematopoietic support, and ability to promote stem cell engraftment. Furthermore, MSCs exhibit low immunogenicity and unique immunomodulatory effects, capable of evading immune recognition, suppressing immune responses, and possessing homing and damage chemotaxis.
Shenzhen  Cell Valleyprovides high-purity, high-vitality MSCs for basic and clinical research.

Production process

Mesenchymal stem cell production process


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact：Ms. Lai

Email：laijiaqi@wfzydp.com

Address：No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Shenzhen Cell Valley Biopharmaceutical Co., Ltd. is a leading one-stop comprehensive outsourcing service provider for China’s cell and gene therapy industry. It is also among the first domestic CRO/CDMO enterprises to hold GMP-compliant industrial production capabilities for clinical-grade retroviral vectors. As a key project for the construction of Shenzhen’s public technical service platform for CRO/CDMO, the company has been listed in the city’s newly announced "20+8" strategic emerging industries initiative.
Shenzhen Cell Valley is equipped with the capacity to conduct standardized and industrialized production of GMP-grade cellular products including CAR-T cells. Its core production lines cover a full spectrum of cellular products such as CAR-T, CAR-NK, CAR-M, γδT, TIL and TCR-T. In addition, the company runs production lines for a diverse range of viral vectors (including RVV, LVV and AAV) and non-viral vectors, as well as for cellular raw materials for therapeutic development—such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses and vaccines.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书：(粤)-非经营性-2022-0426  Technical Support：YouDian Software